NJ State Employees Deferred Compensation Plan’s Concentrix CNXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-5,000
Closed -$231K 87
2025
Q3
$231K Hold
5,000
0.03% 390
2025
Q2
$264K Hold
5,000
0.03% 365
2025
Q1
$278K Hold
5,000
0.04% 366
2024
Q4
$216K Hold
5,000
0.03% 412
2024
Q3
$256K Hold
5,000
0.03% 399
2024
Q2
$316K Hold
5,000
0.04% 360
2024
Q1
$331K Hold
5,000
0.04% 360
2023
Q4
$491K Hold
5,000
0.07% 292
2023
Q3
$401K Hold
5,000
0.06% 305
2023
Q2
$404K Sell
5,000
-947
-16% -$88.6K 0.06% 320
2023
Q1
$723K Hold
5,947
0.11% 205
2022
Q4
$792K Hold
5,947
0.13% 175
2022
Q3
$664K Hold
5,947
0.11% 196
2022
Q2
$806K Hold
5,947
0.13% 171
2022
Q1
$991K Hold
5,947
0.13% 162
2021
Q4
$1.06M Hold
5,947
0.13% 171
2021
Q3
$1.05M Hold
5,947
0.14% 155
2021
Q2
$956K Hold
5,947
0.13% 169
2021
Q1
$891K Hold
5,947
0.13% 175
2020
Q4
$587K Buy
+5,947
New +$594K 0.09% 228

Other funds holding CNXC

NJ State Employees Deferred Compensation Plan's CNXC Position: Q4 2025 in Review

NJ State Employees Deferred Compensation Plan sold out of Concentrix (CNXC) in Q4 2025, closing a stake of 5,000 shares — an estimated $231K sold.

NJ State Employees Deferred Compensation Plan first reported a position in CNXC in Q4 2020 and held it in 20 quarters. The position peaked at $1.06M in Q4 2021. 336 funds tracked by Wall St. Rank hold CNXC as of Q4 2025.

  • NJ State Employees Deferred Compensation Plan reported no remaining Concentrix position as of Q4 2025 after selling out during the quarter.
  • NJ State Employees Deferred Compensation Plan sold 5,000 Concentrix shares in Q4 2025, an estimated $231K.
  • NJ State Employees Deferred Compensation Plan first reported a position in Concentrix in Q4 2020 and held it in 20 quarters.
  • NJ State Employees Deferred Compensation Plan's Concentrix position peaked at $1.06M in Q4 2021.
  • 336 funds tracked by Wall St. Rank held Concentrix as of Q4 2025.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q4 2025.